Prognos Health provides a healthcare analytics platform that integrates and harmonizes de-identified clinical and genomic laboratory data from over 325 million patients, enabling rapid access to actionable insights. This platform addresses the challenge of fragmented health data by offering streamlined access to comprehensive real-world data, facilitating improved patient outcomes and more effective commercial analytics.
Funding
$23.3M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
MWSSFounders
Product
Problem
Life sciences companies face challenges in accessing and integrating comprehensive clinical and genomic data to accelerate the development and delivery of innovative therapies. Fragmented and siloed data hinders effective commercial analytics, HCP targeting, and patient journey analysis, delaying access to potentially life-saving treatments.
Solution
Prognos Health provides a real-world data (RWD) marketplace that integrates and harmonizes de-identified clinical and genomic laboratory data from over 325 million patients, enabling rapid access to actionable insights. The platform streamlines the process of licensing clinical and genomic laboratory data, allowing users to focus on analysis rather than data ingestion. By connecting an extensive network of data providers and applying a proprietary data harmonization and enrichment process, Prognos Health offers unique advantages, including exclusive access to healthcare professionals and patients, diverse oncology genomics data, and transparency of sources. This empowers life sciences companies to improve patient outcomes, maximize sales and marketing efforts, and accelerate the development and delivery of innovative therapies.
Target Audience
The primary customers are life sciences and pharmaceutical companies seeking to accelerate the development and delivery of innovative therapies, improve patient outcomes, and maximize the effectiveness of their commercial analytics and marketing efforts.
Features
- Harmonized and enriched data from diverse sources, ensuring accuracy and completeness.
- Exclusive datasets that unlock valuable insights in complex clinical populations.
- Integration with the Datavant token, accelerating time to value for commercial use cases.
- Access to a large and diverse dataset of real-world data, easily linked to other sources.
- In-depth clinical lab and claims data providing unique insights across hundreds of therapeutic areas.
- Precision Marketing suite to pinpoint high-value prescribers and gain deep patient insights.
- Coverage of oncology genomics data in academic and community-based settings, tissue type (liquid and solid tissue), and testing platforms (NGS, IHC, PCR, FISH, and more).
- Access to the top three national labs on Datavant token and the largest Liquid Biopsy (LB) and Comprehensive Genomic Profiling (CGP) testing lab in the US.